ClinicalTrials.Veeva

Menu

Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic (TDCSSCHIZ)

N

Nathan Kline Institute for Psychiatric Research

Status

Completed

Conditions

Cigarette Smoking
Schizophrenia
Cognition

Treatments

Device: tDCS

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a study of the effects of tDCS on smoking, craving for cigarettes, cognition, and psychiatric symptoms in schizophrenic patients who are current smokers or have a history of regular cigarette smoking. It assesses smoking with CO monitoring, nicotine and nicotine levels, and craving with QSU scale and response to craving slides. Cognition is measured by MCCB, symptoms are measured by PANSS and hallucination scale.

This is a double-blind sham-controlled study with active tDCS 2ma or 20 minutes over 5 days, and sham tDCS for 40 seconds on each sham occasion.

Enrollment

33 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of schizophrenia spectrum disorder History of cigarette smoking

Exclusion criteria

  • Seizure disorder or current treated neurological illness Current Acute exacerbation of psychotic state

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

33 participants in 2 patient groups

Active tDCS
Experimental group
Description:
tDCS 2 ma for 20 minutes with anode at DLPFC once a day for 5 days
Treatment:
Device: tDCS
Sham tDCS
Sham Comparator group
Description:
tDCS 2 ma for 40 seconds with anode at DLPFC for 5 days
Treatment:
Device: tDCS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems